ArticleOncotarget2013

Impact of a genomic classifier of metastatic risk on postoperative treatment recommendations for prostate cancer patients: a report from the DECIDE study group.

Ketan Badani et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.